Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproic acid versus dienogest for endometriosis symptoms
IRCT20240109060656N8Phase 2Not yet recruiting
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial in endometriosis comparing Dienogest with Valproic acid (2 arms). Primary endpoint: Severity of endometriosis-associated pelvic pain at 6 months. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
dienogestvalproic acid
03
Conditions
endometriosis
Beyond the preview
Go deeper on IRCT20240109060656N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240109060656N8.